ELV
Elevance Health Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$407.50
−1.76%Year over year
Reported trailing growth
- Revenue
- +6.3%
- EBITDA
- -18.9%
- EBIT
- -16.2%
- EPS
- -4.5%
- Free cash flow
- +17.8%
- Operating cash flow
- +15.6%
Forward estimates
Based on analyst estimates
- Revenue
- -1.2%
- EBITDA
- +14.5%
- EPS
- +21.2%
Three-year CAGR
- Revenue
- +8.3%
- EBITDA
- -1.6%
- EBIT
- -1.4%
- Net income
- -1.3%
- EPS
- +0.8%
- Free cash flow
- -24.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026